Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Doubles Down on Insomnia with Hypnion Acquisition

Mar 01 2007

• By Chris Morrison

Related Content

Merck Deal Gives Lundbeck US Foothold

Mar 01 2004

Insomnia: Pharma Wakes Up to the Next Huge CNS Market

Feb 01 2006

Hypnion Inc.

Apr 01 2003

The Infrastructure Dilemma

Jan 01 2003

Overheard at JP Morgan's 25th Health Care Conference: Making Up for Lost Drugs: Pharma Attempts to Appease Investors

Feb 01 2007

Related Companies

Eli Lilly and Company

Neurocrine Biosciences, Inc.

Somaxon Pharmaceuticals, Inc.

Pfizer Inc.

H. Lundbeck A/S

Merck & Co., Inc.

Sanofi

Sumitomo Pharma Co., Ltd.

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window